Clinical trial Recruiting at 3 sites Interventional Ages 60 and up

Finding and treating long-term effects of repeated mild brain injuries in older adults

Official title: Developing an Evidence-based Approach to Diagnose and Treat Adults With a History of Concussion

Run by Université de Montréal · NCT07025317 · Data updated 2026-11-12

This project will test whether combining NeuroTracker, MRI, and blood biomarkers can find long-term effects of past concussions and whether NeuroTracker training can improve thinking in adults aged 60 and older with a history of concussion.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversité de Montréal
Academic / other
Locations3 sites (Victoria, British Columbia and 2 other locations)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedJuly 15, 2025
Study endsFebruary 28, 2027
Registry record updatedJuly 20, 2025
Trial IDNCT07025317 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 60 or older with a history of one or more concussions (most recent at least one year ago), who can undergo MRI, blood draws, and computer-based cognitive testing and do not have a diagnosed neurological disorder.

Probably not a fit

People with diagnosed neurodegenerative disorders (for example, established dementia), recent concussions within the past year, inability to undergo MRI or blood draws, or who cannot participate in computer-based training are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project combines NeuroTracker-based perceptual-cognitive testing and training with advanced MRI scans and blood-based biomarkers to detect lingering effects of past mild traumatic brain injuries in older adults. Researchers will enroll men and women aged 60+ with and without a history of concussion (most recent concussion at least one year prior) and compare cognitive, imaging, and biomarker profiles. Participants will undergo baseline cognitive testing, MRI, and blood draws; those with concussion history will receive NeuroTracker training with pre- and post-intervention measurements. The goal is to determine whether this multimodal approach improves sensitivity for detecting long-term concussion effects and whether NeuroTracker can produce measurable cognitive benefits.

Why it matters

Potential benefit: If successful, this approach could enable earlier detection of subtle long-term concussion effects and provide a non-invasive NeuroTracker training that improves cognitive performance in older adults with prior concussions.

How similar studies have gone: Early studies suggest NeuroTracker can detect attentional deficits and sometimes improve cognitive performance, but combining it with MRI and blood biomarkers for long-term concussion effects is relatively novel and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* It will be based on age (60+ years) and history of concussion (with the most recent concussion occurring at least one year prior to the study). Consistent with the literature, the history of concussion will be determined by interviewing participants about their experience with each experience of concussion (e.g. how was the injury sustained (sports injury, vehicle accident, etc.), how long has it been since the injury, did they experience a loss of consciousness during the event, how was their concussion diagnosed, what were their symptoms and when did the symptoms resolve).

The interview will also gather information on age, sex, gender, education, occupation, and medical history (e.g. mood, medications). These variables will be coded and included in analyses, as appropriate. For example, years of education and years since the most recent concussion can be used as covariates.

Exclusion Criteria:

* Include the presence of a diagnosed neurological disorder (e.g. Mild Cognitive Impairment, Alzheimer's disease, Parkinson's disease), history of severe psychiatric disorder (e.g. schizophrenia), or any condition or medication that could affect cognition (e.g. psychotropic, anticholinergic drugs). Exclusion criteria also screen out the presence of any diagnosed visual impairment that could impede NeuroTracker training (i.e. severe colour blindness, monocular vision, blindness), and contraindications for MRI (e.g. metal implants).

Where it's running

  • Christie Lab
    Victoria, British Columbia, Canada
    Recruiting
  • Jodie Gawryluk
    Victoria, British Columbia, Canada
    Recruiting
  • Faubert Lab
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.